FusionPharm posts 38% revenue growth
15 Janeiro 2014 - 12:00PM
FusionPharm, Inc, OTCBB:(FSPM) (www.fusionpharminc.com), the Denver
based manufacturer of the PharmPods™ cultivation system
(www.pharmpods.com) is pleased to announce that it posted 38%
revenue growth, quarter to quarter, for the period ended September
30, 2013. The company anticipates posting it's year end
results before the end of February, 2014.
"Our third quarter results are but an indicator
of things to come " commented company CEO Scott Dittman. "We
have completed our retrofit of our new Denver manufacturing and
sales facility and are busily filling orders bound for customers in
both the United States and Canada. We couldn't be more
excited about the future."
About FusionPharm Inc.
(FSPM)
FusionPharm, Inc. (FSPM)
(www.fusionpharminc.com) was organized to capitalize on
opportunities present in the rapidly growing vertical farming and
cannabis industries. FusionPharm's primary focus is the development
and deployment of the patent pending PharmPods™ advanced hydroponic
commercial cultivation systems. PharmPods are constructed from
standard ISO steel shipping containers that are repurposed for use
in indoor controlled environment agriculture. Modular, stackable,
cost competitive and financeable, PharmPods have become the
industry leader for professional, commercial scale indoor plant
cultivation.
NOTES ABOUT FORWARD-LOOKING
STATEMENTS: Except for any historical information
contained herein, the matters discussed in this press release
contain forward-looking statements that involve risks and
uncertainties, including those described in the Company's
Securities and Exchange Commission reports and filings. Certain
statements contained in this release that are not historical facts
constitute forward-looking statements, within the meaning of the
Private Securities Litigation Reform Act of 1995, and are intended
to be covered by the safe harbors created by that Act. Reliance
should not be placed on forward-looking statements because they
involve unknown risks, uncertainties and other factors, which may
cause actual results, performance or achievements to differ
materially from those expressed or implied. Forward-looking
statements may be identified by words such as estimates,
anticipates, projects, plans, expects, intends, believes, should
and similar expressions and by the context in which they are used.
Such statements are based upon current expectations of the Company
and speak only as of the date made. The Company undertakes no
obligation to update any forward-looking statements to reflect
events or circumstances after the date on which they are made.
CONTACT: info@fusionpharminc.com
Fusion Pharm (CE) (USOTC:FSPM)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Fusion Pharm (CE) (USOTC:FSPM)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
Notícias em tempo-real sobre Fusion Pharm Inc (CE) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de